List of Tables
Table 1. Global Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2024 VS 2031
Table 2. Key Players of Chemotherapy
Table 3. Key Players of Targeted Therapy
Table 4. Key Players of Immunotherapy
Table 5. Global Non Small Cell Lung Cancer Treatment Market Size Growth by Application (US$ Million): 2020 VS 2024 VS 2031
Table 6. Global Non Small Cell Lung Cancer Treatment Market Size by Region (US$ Million): 2020 VS 2024 VS 2031
Table 7. Global Non Small Cell Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 8. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2020-2025)
Table 9. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Region (2026-2031) & (US$ Million)
Table 10. Global Non Small Cell Lung Cancer Treatment Market Share by Region (2026-2031)
Table 11. Non Small Cell Lung Cancer Treatment Market Trends
Table 12. Non Small Cell Lung Cancer Treatment Market Drivers
Table 13. Non Small Cell Lung Cancer Treatment Market Challenges
Table 14. Non Small Cell Lung Cancer Treatment Market Restraints
Table 15. Global Non Small Cell Lung Cancer Treatment Revenue by Players (2020-2025) & (US$ Million)
Table 16. Global Non Small Cell Lung Cancer Treatment Market Share by Players (2020-2025)
Table 17. Global Top Non Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2024)
Table 18. Ranking of Global Top Non Small Cell Lung Cancer Treatment Companies by Revenue (US$ Million) in 2024
Table 19. Global 5 Largest Players Market Share by Non Small Cell Lung Cancer Treatment Revenue (CR5 and HHI) & (2020-2025)
Table 20. Global Key Players of Non Small Cell Lung Cancer Treatment, Headquarters and Area Served
Table 21. Global Key Players of Non Small Cell Lung Cancer Treatment, Product and Application
Table 22. Global Key Players of Non Small Cell Lung Cancer Treatment, Date of Enter into This Industry
Table 23. Mergers & Acquisitions, Expansion Plans
Table 24. Global Non Small Cell Lung Cancer Treatment Market Size by Type (2020-2025) & (US$ Million)
Table 25. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2020-2025)
Table 26. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Type (2026-2031) & (US$ Million)
Table 27. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Type (2026-2031)
Table 28. Global Non Small Cell Lung Cancer Treatment Market Size by Application (2020-2025) & (US$ Million)
Table 29. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Application (2020-2025)
Table 30. Global Non Small Cell Lung Cancer Treatment Forecasted Market Size by Application (2026-2031) & (US$ Million)
Table 31. Global Non Small Cell Lung Cancer Treatment Revenue Market Share by Application (2026-2031)
Table 32. North America Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 33. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 34. North America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 35. Europe Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 36. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 37. Europe Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 38. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Region (US$ Million): 2020 VS 2024 VS 2031
Table 39. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2020-2025) & (US$ Million)
Table 40. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size by Region (2026-2031) & (US$ Million)
Table 41. Latin America Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 42. Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 43. Latin America Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 44. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size Growth Rate by Country (US$ Million): 2020 VS 2024 VS 2031
Table 45. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2020-2025) & (US$ Million)
Table 46. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size by Country (2026-2031) & (US$ Million)
Table 47. Novartis AG Company Details
Table 48. Novartis AG Business Overview
Table 49. Novartis AG Non Small Cell Lung Cancer Treatment Product
Table 50. Novartis AG Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 51. Novartis AG Recent Development
Table 52. Pfizer Inc Company Details
Table 53. Pfizer Inc Business Overview
Table 54. Pfizer Inc Non Small Cell Lung Cancer Treatment Product
Table 55. Pfizer Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 56. Pfizer Inc Recent Development
Table 57. Sanofi Company Details
Table 58. Sanofi Business Overview
Table 59. Sanofi Non Small Cell Lung Cancer Treatment Product
Table 60. Sanofi Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 61. Sanofi Recent Development
Table 62. F. Hoffmann-La Roche Ltd Company Details
Table 63. F. Hoffmann-La Roche Ltd Business Overview
Table 64. F. Hoffmann-La Roche Ltd Non Small Cell Lung Cancer Treatment Product
Table 65. F. Hoffmann-La Roche Ltd Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 66. F. Hoffmann-La Roche Ltd Recent Development
Table 67. Astrazeneca Company Details
Table 68. Astrazeneca Business Overview
Table 69. Astrazeneca Non Small Cell Lung Cancer Treatment Product
Table 70. Astrazeneca Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 71. Astrazeneca Recent Development
Table 72. Eli Lilly and Company Company Details
Table 73. Eli Lilly and Company Business Overview
Table 74. Eli Lilly and Company Non Small Cell Lung Cancer Treatment Product
Table 75. Eli Lilly and Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 76. Eli Lilly and Company Recent Development
Table 77. Merck & Co Inc Company Details
Table 78. Merck & Co Inc Business Overview
Table 79. Merck & Co Inc Non Small Cell Lung Cancer Treatment Product
Table 80. Merck & Co Inc Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 81. Merck & Co Inc Recent Development
Table 82. Bristol-Myers Squibb Company Company Details
Table 83. Bristol-Myers Squibb Company Business Overview
Table 84. Bristol-Myers Squibb Company Non Small Cell Lung Cancer Treatment Product
Table 85. Bristol-Myers Squibb Company Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 86. Bristol-Myers Squibb Company Recent Development
Table 87. Celgene Corporation Company Details
Table 88. Celgene Corporation Business Overview
Table 89. Celgene Corporation Non Small Cell Lung Cancer Treatment Product
Table 90. Celgene Corporation Revenue in Non Small Cell Lung Cancer Treatment Business (2020-2025) & (US$ Million)
Table 91. Celgene Corporation Recent Development
Table 92. Research Programs/Design for This Report
Table 93. Key Data Information from Secondary Sources
Table 94. Key Data Information from Primary Sources
Table 95. Authors List of This Report
List of Figures
Figure 1. Non Small Cell Lung Cancer Treatment Picture
Figure 2. Global Non Small Cell Lung Cancer Treatment Market Size Comparison by Type (2020-2031) & (US$ Million)
Figure 3. Global Non Small Cell Lung Cancer Treatment Market Share by Type: 2024 VS 2031
Figure 4. Chemotherapy Features
Figure 5. Targeted Therapy Features
Figure 6. Immunotherapy Features
Figure 7. Global Non Small Cell Lung Cancer Treatment Market Size by Application (2020-2031) & (US$ Million)
Figure 8. Global Non Small Cell Lung Cancer Treatment Market Share by Application: 2024 VS 2031
Figure 9. Hospital Case Studies
Figure 10. Clinic Case Studies
Figure 11. Others Case Studies
Figure 12. Non Small Cell Lung Cancer Treatment Report Years Considered
Figure 13. Global Non Small Cell Lung Cancer Treatment Market Size (US$ Million), Year-over-Year: 2020-2031
Figure 14. Global Non Small Cell Lung Cancer Treatment Market Size, (US$ Million), 2020 VS 2024 VS 2031
Figure 15. Global Non Small Cell Lung Cancer Treatment Market Share by Region: 2024 VS 2031
Figure 16. Global Non Small Cell Lung Cancer Treatment Market Share by Players in 2024
Figure 17. Global Top Non Small Cell Lung Cancer Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non Small Cell Lung Cancer Treatment as of 2024)
Figure 18. The Top 10 and 5 Players Market Share by Non Small Cell Lung Cancer Treatment Revenue in 2024
Figure 19. North America Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 20. North America Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 21. United States Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 22. Canada Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 23. Europe Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 24. Europe Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 25. Germany Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 26. France Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 27. U.K. Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 28. Italy Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 29. Russia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 30. Nordic Countries Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 31. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 32. Asia-Pacific Non Small Cell Lung Cancer Treatment Market Share by Region (2020-2031)
Figure 33. China Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 34. Japan Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 35. South Korea Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 36. Southeast Asia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 37. India Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 38. Australia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 39. Latin America Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 40. Latin America Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 41. Mexico Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 42. Brazil Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 43. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 44. Middle East & Africa Non Small Cell Lung Cancer Treatment Market Share by Country (2020-2031)
Figure 45. Turkey Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 46. Saudi Arabia Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 47. UAE Non Small Cell Lung Cancer Treatment Market Size YoY Growth (2020-2031) & (US$ Million)
Figure 48. Novartis AG Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 49. Pfizer Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 50. Sanofi Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 51. F. Hoffmann-La Roche Ltd Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 52. Astrazeneca Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 53. Eli Lilly and Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 54. Merck & Co Inc Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 55. Bristol-Myers Squibb Company Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 56. Celgene Corporation Revenue Growth Rate in Non Small Cell Lung Cancer Treatment Business (2020-2025)
Figure 57. Bottom-up and Top-down Approaches for This Report
Figure 58. Data Triangulation
Figure 59. Key Executives Interviewed
